No significant difference in TIMP-1 levels between low/moderate-grade and high-grade/invasive IPMN; no significant difference in the urinary expression of LYVE-1 and PGEM between PC, IPMN, and healthy controls. Here, TIMP1 is linked to pancreatic intraductal papillary-mucinous neoplasm.